kyron.bio awarded 2025 EIC Transition

kyron.bio is awarded a €2.5M EIC Transition grant, a highly competitive European grant awarded to technologies that are ready to make the leap from the lab to the market. The grant was awarded to kyron.bio and their consortium partner, Genos Glyco, after the highest number of applicants on record. This award highlights the European Union’s recognition of the innovative potential of glycan engineering to create safer and more effective therapies for patients.